Individual dosage of digoxin in patients with heart failure

Authors: Muzzarelli, S.1; Stricker, H.2; Pfister, O.3; Foglia, P.4; Moschovitis, G.5; Mombelli, G.2; Brunner-La Rocca, H.6

Source: QJM: An International Journal of Medicine, Volume 104, Number 4, 23 April 2011 , pp. 309-317(9)

Publisher: Oxford University Press

Buy & download fulltext article:

OR

Price: $44.11 plus tax (Refund Policy)

Abstract:

Backgroud: After the publication of DIG trial, the therapeutic target of serum digoxin concentration (SDC) for the treatment of heart failure (HF) has been lowered (0.401.00ng/ml). However, the majority of equations to calculate digoxin dosages were developed for higher SDCs. Recently, a new equation was validated in Asian population for low SDCs by Konishi et al., but results in Caucasians are unknown.

Aim: This study was aimed to test the Konishi equation in Caucasians specifically targeting low SDCs. Furthermore, the Konishi equation was compared with other frequently used equations.

Design: This was a prospective, multicenter study.

Methods: Clinically indicated digoxin was given in 40 HF patients. The dosage was calculated with the Konishi equation. The SDC was measured at 1 and 6 months after starting digoxin. Adherence to digoxin was monitored with a specific questionnaire.

Results: After exclusion of patients admitting poor adherence, we found a reasonable correlation between predicted and measured SDC (r0.48; P<0.01) by the Konishi equation. Excluding patients with poor adherence and relevant worsening of renal function, the measured SDC (n54 measurements) was within the pre-defined therapeutic range in 95 of the cases. The mean, maximal and minimal measured SDC were 0.690.19, 1.00 and 0.32ng/ml, respectively. The correlation was weaker for the Jelliffe, the Koup and Jusko, and the Bauman equations.

Conclusions: This study supports the clinical validity of the Konishi equation for calculating individual digoxin dosage in Caucasians, targeting SDCs according to current HF guidelines.

Document Type: Research article

DOI: http://dx.doi.org/10.1093/qjmed/hcq196

Affiliations: 1: Cardiology Department, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland, Radiology Department, Cardiac and Pulmonary Imaging, University of California, San Francisco, California, USA, , 2: Department of Internal Medicine, Regional Hospital of Locarno, Via all'Ospedale 1, CH-6600 Locarno, , 3: Cardiology Department, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland, , 4: Department of Internal Medicine, Regional Hospital of Locarno, Via all'Ospedale 1, CH-6600 Locarno, Cardiology Department, University Hospital Bern, Freiburgstrasse, CH-3010 Bern, , 5: Cardiology Department, Regional Hospital of Lugano, Via Tesserete, CH-6900 Lugano, Switzerland and , 6: Cardiology Department, University Hospital Maastricht, P. Debyelaan 25, NL-6202 AZ Maastricht, The Netherlands,

Publication date: 2011-04-23

More about this publication?
  • QJM is a long-established, leading general medical journal. It focuses on internal medicine and publishes peer-reviewed articles which promote medical science and practice. Published monthly, QJM includes original papers, editorials, reviews, commentary papers to air controversial issues, and a correspondence column.
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page